|
Jim Larrick enjoys an international reputation in biotechnology (cytokines, therapeutic antibodies, molecular biology, pharmaceutical drug development) having written or co-authored eight books, over 220 papers/chapters and fifteen patents. He serves on the editorial board of six journals. Dr. Larrick received his M.D. and Ph.D. degrees from Duke University School of Medicine, Durham, NC. After house staff training in the Department of Medicine at Stanford University School of Medicine, he completed a post-doctoral fellowship in the Stanford Cancer Biology Research Labs with Professor Henry S. Kaplan. Dr. Larrick has also founded more than a dozen biopharmaceutical companies. | 